Results for tag: "Digeorge Syndrome Drug"

DiGeorge Syndrome (DGS) is a rare genetic disorder caused by a deletion of a small piece of chromosome 22. It is characterized by a wide range of physical and developmental abnormalities, including heart defects, immune system deficiencies, and learning disabilities. Endocrine and Metabolic Disorders Drugs are used to treat the symptoms of DGS, including hormone replacement therapy, calcium and vitamin D supplementation, and anticonvulsants. Additionally, drugs are used to treat the underlying causes of DGS, such as hypoparathyroidism, hypocalcemia, and cardiac arrhythmias. The DiGeorge Syndrome Drug market is a niche market, with a limited number of drugs available to treat the condition. The market is highly specialized, with drugs tailored to the specific needs of DGS patients. As such, the market is highly competitive, with companies vying for market share. Companies in the market include AbbVie, Pfizer, Merck, and Novartis. Show Less Read more